New dual dog and cat branded packaging

0
441

AUS_Comf_LeftF_group_web

Comfortis® – The #1 canine flea treatment recommended by Australian veterinarians1

With more than 13 million doses dispensed since launching in 2009, Comfortis® has earned the trust of veterinarians throughout Australia and New Zealand and it’s not hard to see why.

Studies show that Comfortis starts to kill fleas within 30 minutes in dogs and cats and is 100% and >95% effective in 4 hours in dogs and cats respectively,2,3 providing rapid and lasting relief from fleas for a whole month.4-6

Comfortis kills fleas so quickly that it minimises the opportunity for fleas to feed and reduces the clinical severity of skin disorders including flea allergy dermatitis (FAD) and pruritus in dogs and cats.4-8

Due to its proven efficacy and speed of kill, supported by trial data2-8, and borne out by field use experience, Comfortis has earned a reputation as a trusted solution to flea problems.

Pet owners trust their vet’s recommendation and, as such, it’s important that you continue to recommend a product that works first time, every time.

With dual dog and cat branded packaging about to hit the Australian marketplace, Comfortis will be convenient for pet owners trying to eliminate fleas without requiring veterinarians to stock additional lines of flea products to cover both species.

Combined with the convenience of a beef flavoured chewable tablet, oral administration ensures Comfortis won’t rub or wash off over the summer months.

Elanco, the manufacturers of Comfortis, understand the key role veterinarians play in assisting pet owners to help their pets live longer, healthier, higher-quality lives and we work hard to drive sales back through veterinary clinics and in turn, deliver on our mission statement; ‘Helping vets help pets live longer, healthier, higher quality lives’.

Elanco lives this mission statement though the support of vet-driven charitable organisations such as Pets In The Park and veterinary-exclusive pet owner promotions designed to keep product sales in your practice.

We would like to take this opportunity to thank the veterinary community for your continued support of our full range of products and services.

To book a training session for your staff or discuss your point-of-sale needs, please contact your local Elanco representative, or call Elanco Technical Services on 1800 995 709.

©2014 Elanco, a division of Eli Lilly and Company Limited. Elanco and Comfortis are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates.

References: 1. Cegedim: Veterinarians Comfortis Survey December 2012 (Australia) commissioned by Elanco. Survey data on file. Statistically significant difference in one-tailed test versus the number two veterinary recommended flea product for dogs. 2. Elanco study T9C060330, data on file. 3. Elanco study T9CUS100015, data on file. 4. Elanco study T9CAL0401, data on file. 5. Elanco study

T9CAL0403, data on file. 6. Elanco Study T9CAU100039, data on file. 7. Dryden MW, Ryan WG, Bell M et al. Assessment of owner-administered monthly treatments with oral spinosad or topical spot-on fipronil/(S)-methoprene in controlling fleas and associated pruritus in dogs. Veterinary Parasitology, 2013; 191(3-4): 340-346. 8. Paarlberg TE, Wiseman S, Trout CE et al. Safety and efficacy of spinosad chewable tablets for treatment of flea infestation of cats. JAVMA, 2013; 242(8):1092-1098.

LEAVE A REPLY

Please enter your comment!
Please enter your name here